These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 9507661

  • 1. Quinoxaline chemistry. Part 8. 2-[Anilino]-3-[carboxy]-6(7)-substituted quinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity.
    Loriga M, Moro P, Sanna P, Paglietti G, Zanetti S.
    Farmaco; 1997; 52(8-9):531-7. PubMed ID: 9507661
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Quinoxaline chemistry. Part 5. 2-(R)-benzylaminoquinoxalines as nonclassical antifolate agents. Synthesis and evaluation of in vitro anticancer activity.
    Loriga M, Fiore M, Sanna P, Paglietti G.
    Farmaco; 1996; 51(8-9):559-68. PubMed ID: 8930109
    [Abstract] [Full Text] [Related]

  • 4. Quinoxaline chemistry. Part 4. 2(R)-anilinoquinoxalines as nonclassical antifolate agents. Synthesis, structure elucidation and evaluation of in vitro anticancer activity.
    Loriga M, Fiore M, Sanna P, Paglietti G.
    Farmaco; 1995 May; 50(5):289-301. PubMed ID: 7626163
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione.
    El-Hawash SA, Wahab AE.
    Arch Pharm (Weinheim); 2006 Aug; 339(8):437-47. PubMed ID: 16881038
    [Abstract] [Full Text] [Related]

  • 6. Quinoxaline chemistry. Part 16. 4-substituted anilino and 4-substituted phenoxymethyl pyrrolo[1,2-a]quinoxalines and N-[4-(pyrrolo[1,2-a]quinoxalin-4-yl)amino and hydroxymethyl]benzoyl glutamates. Synthesis and evaluation of in vitro biological activity.
    Alleca S, Corona P, Loriga M, Paglietti G, Loddo R, Mascia V, Busonera B, La Colla P.
    Farmaco; 2003 Sep; 58(9):639-50. PubMed ID: 13679156
    [Abstract] [Full Text] [Related]

  • 7. Quinoxaline chemistry. Part 12. 3-Carboxy-2[phenoxy]-6(7)substituted quinoxalines and N-[4-(6(7) substituted-3-carboxyquinoxalin-2-yl)hydroxy] benzoylglutamates. Synthesis and evaluation of in vitro anticancer activity.
    Vitale G, Corona P, Loriga M, Paglietti G.
    Farmaco; 1998 Sep; 53(8-9):594-601. PubMed ID: 10081824
    [Abstract] [Full Text] [Related]

  • 8. Synthesis of some new quinoxalines and 1,2,4-triazolo[4,3-a]-quinoxalines for evaluation of in vitro antitumor and antimicrobial activities.
    El-Hawash SA, Habib NS, Kassem MA.
    Arch Pharm (Weinheim); 2006 Oct; 339(10):564-71. PubMed ID: 17009301
    [Abstract] [Full Text] [Related]

  • 9. New alpha-(N)-heterocyclichydrazones: evaluation of anticancer, anti-HIV and antimicrobial activity.
    Savini L, Chiasserini L, Travagli V, Pellerano C, Novellino E, Cosentino S, Pisano MB.
    Eur J Med Chem; 2004 Feb; 39(2):113-22. PubMed ID: 14987820
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives.
    Zarranz B, Jaso A, Aldana I, Monge A.
    Bioorg Med Chem; 2004 Jul 01; 12(13):3711-21. PubMed ID: 15186857
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides.
    Carta A, Loriga M, Paglietti G, Mattana A, Fiori PL, Mollicotti P, Sechi L, Zanetti S.
    Eur J Med Chem; 2004 Feb 01; 39(2):195-203. PubMed ID: 14987828
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.